Advertisement

Hysteroscopy pp 303-314 | Cite as

Hysteroscopy and Contraception: An Overview

Chapter

Abstract

Hysteroscopy and contraception have always been closely related, albeit perhaps not always in daily practice, but ever since the existence of hysteroscopy pioneers have tried to find ways to perform sterilization through this route.

This chapter gives an overview of the history of hysteroscopic sterilization, of the systems that are or have been on the market, of research that has been performed on this subject, and of possible future developments.

The latest data on actual items such as late adverse effects of implants will also be addressed.

Keywords

Hysteroscopy Sterilization Contraception Female Essure® Adiana® Ovabloc® Altaseal® 

References

  1. 1.
    EngenderHealth. Contraceptive sterilization: global issues and trends. New York, USA: EngenderHealth; 2002.Google Scholar
  2. 2.
    Prismant, Health Care and Advise Institute. Landelijke LMR-informatie – Verrichtingen: destructie of afsluiting van tubae faloppii mbv endoscopie. 2004. Utrecht, The Netherlands, Prismant, Health Care and Advise Institute. Ref Type: Report [Dutch].Google Scholar
  3. 3.
    Hyams MN. Sterilization of the female by coagulation of the uterine cornu. Am J Obstet Gynecol. 1934;28:96.Google Scholar
  4. 4.
    Steptoe P. Laparoscopic tubal sterilization—a British viewpoint. IPPF Med Bull. 1971;5(2):4.PubMedGoogle Scholar
  5. 5.
    Bosch PF. Laparoskopische sterilization. Schweizerische Zeitschrift fur Krankenhaus und Anstaltswesen. 1936;6:62. [German]Google Scholar
  6. 6.
    Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol. 1996;174(4):1161–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Jansen FW, Kapiteyn K, Trimbos-Kemper T, Hermans J, Trimbos JB. Complications of laparoscopy: a prospective multicentre observational study. Br J Obstet Gynaecol. 1997;104(5):595–600.CrossRefPubMedGoogle Scholar
  8. 8.
    Vleugels M. Personal communication, based on data collection for a review in press.Google Scholar
  9. 9.
    Personal communication medical director Bayer Netherlands.Google Scholar
  10. 10.
    van der Leij G. Hysteroscopic Sterilization: study of the siloxane intratubal device application method. Dissertation, Universiteit van Amsterdam; 1997.Google Scholar
  11. 11.
    Wamsteker K. Hysteroscopie. Dissertation, Rijksuniversiteit Leiden; 1977.Google Scholar
  12. 12.
    Cooper JM. Hysteroscopic sterilization. Clin Obstet Gynecol. 1992;35(2):282–98.CrossRefPubMedGoogle Scholar
  13. 13.
    Lindemann HJ, Mohr J. Results of 274 trans-uterine tubal sterilizations by hysteroscopy (author’s transl). Geburtshilfe Frauenheilkd. 1974;34(9):775–9.PubMedGoogle Scholar
  14. 14.
    Thatcher SS. Hysteroscopic sterilization. Obstet Gynecol Clin North Am. 1988;15(1):51–9.PubMedGoogle Scholar
  15. 15.
    Brundin J. Transcervical sterilization in the human female by hysteroscopic application of hydrogelic occlusive devices into the intramural parts of the fallopian tubes: 10 years experience of the P-block. Eur J Obstet Gynecol Reprod Biol. 1991;39(1):41–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Hamou J, Gasparri F, Scarselli GF, Mencaglia L, Perino A, Quartararo P, et al. Hysteroscopic reversible tubal sterilization. Acta Eur Fertil. 1984;15(2):123–9.PubMedGoogle Scholar
  17. 17.
    Loffer FD. Hysteroscopic sterilization with the use of formed-in-place silicone plugs. Am J Obstet Gynecol. 1984;149(3):261–70.CrossRefPubMedGoogle Scholar
  18. 18.
    Reed TP, Erb RA. Hysteroscopic oviductal blocking with formed-in-place silicone rubber plugs: II. Clinical studies. J Reprod Med. 1979;23(2):69–72.PubMedGoogle Scholar
  19. 19.
    Ligt-Veneman NG, Tinga DJ, Kragt H, Brandsma G, van der Leij G. The efficacy of intratubal silicone in the Ovabloc hysteroscopic method of sterilization. Acta Obstet Gynecol Scand. 1999;78(9):824–5.CrossRefPubMedGoogle Scholar
  20. 20.
    van der Leij G, Lammes FB. Office hysteroscopic tubal occlusion with siloxane intratubal devices (the Ovabloc method). Int J Gynaecol Obstet. 1996;53(3):253–60.CrossRefGoogle Scholar
  21. 21.
    Bettocchi S, Selvaggi L. A vaginoscopic approach to reduce the pain of office hysteroscopy. J Am Assoc Gynecol Laparosc. 1997;4(2):255–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Belotte J, Shavell VI, Awonuga AO, Diamond MP, Berman JM, Yancy AF. Small bowel obstruction subsequent to Essure microinsert sterilization: a case report. Fertil Steril. 2011;96(1):4–6.CrossRefGoogle Scholar
  23. 23.
    Povedano B, Arjona JE, Velasco E, Monserrat JA, Lorente J, Castelo-Branco C. Complications of hysteroscopic Essure(®) sterilisation: report on 4306 procedures performed in a single centre. BJOG. 2012;119(7):795–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Cooper JM, Carignan CS, Cher D, Kerin JF. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol. 2003;102(1):59–67.PubMedGoogle Scholar
  25. 25.
    Derks R, Stael A. Ileus after Essure sterilization. Medisch Contact. 2011;35:2058. [Dutch]Google Scholar
  26. 26.
    Veersema S, Vleugels M, Koks C, Thurkow A, van der Vaart H, Brölmann H. Confirmation of Essure placement using transvaginal ultrasound. J Minim Invasive Gynecol. 2011;18(2):164–8. Epub 2011 Feb 1CrossRefPubMedGoogle Scholar
  27. 27.
    Vleugels M, Connor V, Bangerter K, Goldstein JA, Cheng R. Transvaginal ultrasound (TVU) for the essure confirmation test: patient satisfaction with TVU [18E]. Obstet Gynecol. 2016;127:47S–8S.CrossRefGoogle Scholar
  28. 28.
    Walter JR, Ghobadi CW, Hayman E, Xu S. Hysteroscopic sterilization with essure: summary of the U.S. Food and Drug Administration actions and policy implications for postmarketing surveillance. Obstet Gynecol. 2017;129(1):10–9.CrossRefPubMedGoogle Scholar
  29. 29.
    The Faculty of Sexual & Reproductive Healthcare of the Royal College of Obstetricians & Gynaecologists (FSRH): CEU Statement: Response to the FDA Review of Essure® (Oct 2015). http://www.fsrh.org/standards-and-guidance/documents/fsrhstatementessure/.
  30. 30.
    [Information for women considering sterilisation] Dutch. NVOG (Nederlandse Vereniging voor Obstetrie en Gynaecologie = Dutch Society for Obstetrics and Gynaecology) Patient Information leaflet. http://www.nvog.nl//Sites/Files/0000004858_Informatie%20voor%20vrouwen%20die%20een%20sterilisatie%20overwegen.pdf.
  31. 31.
    Anderson TL, Vancaillie TG. Adiana system for transcervical sterilization: 3-year efficacy results. J Minim Invasive Gynecol. 2009;16(6):S38.CrossRefGoogle Scholar
  32. 32.
    Thurkow AL. Altaseal hysteroscopic sterilization: the new challenger to essure? JMIG. 2011;18(6):S38.Google Scholar
  33. 33.
    Gannon M. First clinical results of a new hysteroscopic sterilisation device: Altaseal. Int J Gyn Obstet. 2012;119(Suppl 3):S190.CrossRefGoogle Scholar
  34. 34.
    Hasskamp T, Wildemeersch D. A new hysteroscopic technique for reversible long-acting reproductive control (ReLARC®) as an alternative to laparoscopic sterilization and Essure®. Gynecol Reprod Med. 2016;2(4):213–6.Google Scholar
  35. 35.
    Levie M, Chudnoff SG. A comparison of novice and experienced physicians performing hysteroscopic sterilization: an analysis of an FDA-mandated trial. Fertil Steril. 2011;96(3):643–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of GynaecologyAcademic Medical CentreAmsterdamThe Netherlands
  2. 2.Bergman Clinics VrouwenzorgAmsterdamThe Netherlands
  3. 3.DC Klinieken LairesseAmsterdamThe Netherlands

Personalised recommendations